Innate Lymphoid Cells Drive Interleukin-23-dependent Innate Intestinal Pathology

Overview

Journal Nature

Specialty Science

Date 2010 Apr 16

PMID 20393462

Citations 585

Authors

Sofia Buonocore

Philip P Ahern

Holm H Uhlig

Ivaylo I Ivanov

Dan R Littman

Kevin J Maloy

Fiona Powrie

Affiliations

Soon will be listed here.

Abstract

The key role of interleukin (IL)-23 in the pathogenesis of autoimmune and chronic inflammatory disorders is supported by the identification of IL-23 receptor (IL-23R) susceptibility alleles associated with inflammatory bowel disease, psoriasis and ankylosing spondylitis. IL-23-driven inflammation has primarily been linked to the actions of T-helper type 17 (TH17) cells. Somewhat overlooked, IL-23 also has inflammatory effects on innate immune cells and can drive T-cell-independent colitis. However, the downstream cellular and molecular pathways involved in this innate intestinal inflammatory response are poorly characterized. Here we show that bacteria-driven innate colitis is associated with an increased production of IL-17 and interferon-gamma in the colon. Stimulation of colonic leukocytes with IL-23 induced the production of IL-17 and interferon-gamma exclusively by innate lymphoid cells expressing Thy1, stem cell antigen 1 (SCA-1), retinoic-acid-related orphan receptor (ROR)-gammat and IL-23R, and these cells markedly accumulated in the inflamed colon. IL-23-responsive innate intestinal cells are also a feature of T-cell-dependent models of colitis. The transcription factor ROR-gammat, which controls IL-23R expression, has a functional role, because Rag-/-Rorc-/- mice failed to develop innate colitis. Last, depletion of Thy1+ innate lymphoid cells completely abrogated acute and chronic innate colitis. These results identify a previously unrecognized IL-23-responsive innate lymphoid population that mediates intestinal immune pathology and may therefore represent a target in inflammatory bowel disease.

Citing Articles

Dual Therapy in Inflammatory Bowel Disease.

Altieri G, Zilli A, Parigi T, Allocca M, Furfaro F, Fiorino G Biomolecules. 2025; 15(2).

PMID: 40001525 PMC: 11853240. DOI: 10.3390/biom15020222.

Inflammatory disease microbiomes share a functional pathogenicity predicted by C-reactive protein.

Britton G, Mogno I, Chen-Liaw A, Plitt T, Helmus D, Bongers G bioRxiv. 2025; .

PMID: 39868147 PMC: 11761010. DOI: 10.1101/2025.01.14.633015.

Tissue-resident immune cells: from defining characteristics to roles in diseases.

Li J, Xiao C, Li C, He J Signal Transduct Target Ther. 2025; 10(1):12.

PMID: 39820040 PMC: 11755756. DOI: 10.1038/s41392-024-02050-5.

NRP1 instructs IL-17-producing ILC3s to drive colitis progression.

Wang Y, Wang J, Liu G, Yi X, Wu J, Cao H Cell Mol Immunol. 2024; 22(2):161-175.

PMID: 39741194 PMC: 11782674. DOI: 10.1038/s41423-024-01246-7.

Dissecting Innate and Adaptive Immunity in Inflammatory Bowel Disease: Immune Compartmentalization, Microbiota Crosstalk, and Emerging Therapies.

Yue N, Hu P, Tian C, Kong C, Zhao H, Zhang Y J Inflamm Res. 2024; 17:9987-10014.

PMID: 39634289 PMC: 11615095. DOI: 10.2147/JIR.S492079.

References

Martin B, Hirota K, Cua D, Stockinger B, Veldhoen M . Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009; 31(2):321-30. DOI: 10.1016/j.immuni.2009.06.020. View

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

Kullberg M, Jankovic D, Feng C, Hue S, Gorelick P, McKenzie B . IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med. 2006; 203(11):2485-94. PMC: 2118119. DOI: 10.1084/jem.20061082. View

Fallon P, Ballantyne S, Mangan N, Barlow J, Dasvarma A, Hewett D . Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006; 203(4):1105-16. PMC: 2118283. DOI: 10.1084/jem.20051615. View

Uhlig H, McKenzie B, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R . Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity. 2006; 25(2):309-18. DOI: 10.1016/j.immuni.2006.05.017. View

Finke D . Fate and function of lymphoid tissue inducer cells. Curr Opin Immunol. 2005; 17(2):144-50. DOI: 10.1016/j.coi.2005.01.006. View

Zhou L, Ivanov I, Spolski R, Min R, Shenderov K, Egawa T . IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007; 8(9):967-74. DOI: 10.1038/ni1488. View

Marchesi F, Martin A, Thirunarayanan N, Devany E, Mayer L, Grisotto M . CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol. 2009; 2(6):486-94. DOI: 10.1038/mi.2009.113. View

Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H . Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2009; 463(7280):540-4. DOI: 10.1038/nature08636. View

10.

Takatori H, Kanno Y, Watford W, Tato C, Weiss G, Ivanov I . Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med. 2008; 206(1):35-41. PMC: 2626689. DOI: 10.1084/jem.20072713. View

11.

Satoh-Takayama N, Vosshenrich C, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F . Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 2008; 29(6):958-70. DOI: 10.1016/j.immuni.2008.11.001. View

12.

Lee Y, Turner H, Maynard C, Oliver J, Chen D, Elson C . Late developmental plasticity in the T helper 17 lineage. Immunity. 2009; 30(1):92-107. PMC: 3607320. DOI: 10.1016/j.immuni.2008.11.005. View

13.

Sutton C, Lalor S, Sweeney C, Brereton C, Lavelle E, Mills K . Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009; 31(2):331-41. DOI: 10.1016/j.immuni.2009.08.001. View

14.

McGeachy M, Cua D . Th17 cell differentiation: the long and winding road. Immunity. 2008; 28(4):445-53. DOI: 10.1016/j.immuni.2008.03.001. View

15.

Powrie F, Leach M, Mauze S, Menon S, Caddle L, Coffman R . Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1994; 1(7):553-62. DOI: 10.1016/1074-7613(94)90045-0. View

16.

Yeung M, Melgar S, Baranov V, Oberg A, Danielsson A, Hammarstrom S . Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut. 2000; 47(2):215-27. PMC: 1728017. DOI: 10.1136/gut.47.2.215. View

17.

Luci C, Reynders A, Ivanov I, Cognet C, Chiche L, Chasson L . Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol. 2008; 10(1):75-82. DOI: 10.1038/ni.1681. View

18.

Hue S, Ahern P, Buonocore S, Kullberg M, Cua D, McKenzie B . Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006; 203(11):2473-83. PMC: 2118132. DOI: 10.1084/jem.20061099. View

19.

Maloy K, Salaun L, Cahill R, Dougan G, Saunders N, Powrie F . CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med. 2003; 197(1):111-9. PMC: 2193798. DOI: 10.1084/jem.20021345. View

20.

Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz J . A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2008; 457(7230):722-5. PMC: 3772687. DOI: 10.1038/nature07537. View